Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP459054.RAPpC38zeECYJLhmLfPMUvMHXcc5aroHt6KJ5n6d-XCxI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP459054.RAPpC38zeECYJLhmLfPMUvMHXcc5aroHt6KJ5n6d-XCxI130_assertion type Assertion NP459054.RAPpC38zeECYJLhmLfPMUvMHXcc5aroHt6KJ5n6d-XCxI130_head.
- NP459054.RAPpC38zeECYJLhmLfPMUvMHXcc5aroHt6KJ5n6d-XCxI130_assertion description "[The serum CSTB levels were measured using a sandwich ELISA method in four groups, including normal healthy subjects (group 1, n = 52) and patients with noncirrhotic chronic hepatitis (group 2, n = 53), cirrhosis (group 3, n = 43), and HCC (group 4, n = 62).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP459054.RAPpC38zeECYJLhmLfPMUvMHXcc5aroHt6KJ5n6d-XCxI130_provenance.
- NP459054.RAPpC38zeECYJLhmLfPMUvMHXcc5aroHt6KJ5n6d-XCxI130_assertion evidence source_evidence_literature NP459054.RAPpC38zeECYJLhmLfPMUvMHXcc5aroHt6KJ5n6d-XCxI130_provenance.
- NP459054.RAPpC38zeECYJLhmLfPMUvMHXcc5aroHt6KJ5n6d-XCxI130_assertion SIO_000772 18281540 NP459054.RAPpC38zeECYJLhmLfPMUvMHXcc5aroHt6KJ5n6d-XCxI130_provenance.
- NP459054.RAPpC38zeECYJLhmLfPMUvMHXcc5aroHt6KJ5n6d-XCxI130_assertion wasDerivedFrom befree-20140225 NP459054.RAPpC38zeECYJLhmLfPMUvMHXcc5aroHt6KJ5n6d-XCxI130_provenance.
- NP459054.RAPpC38zeECYJLhmLfPMUvMHXcc5aroHt6KJ5n6d-XCxI130_assertion wasGeneratedBy ECO_0000203 NP459054.RAPpC38zeECYJLhmLfPMUvMHXcc5aroHt6KJ5n6d-XCxI130_provenance.